UNSPSC 51433506: Amiquinsin hydrochloride

This classification denotes an antihypertensive agent with the molecular formula C11H12N2O2.ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EZ270U8Z9W, chemically known as 4-quinolinamine, 6,7-dimethoxy-, monohydrochloride, monohydrate but more generally known as amiquinsin hydrochloride, which bears US NIH Compound Identifier 23509. Most nations, for tariff and trade purposes, schedule amiquinsin hydrochloride under HS 29334990 and SITC 51575.

As of Q4 2014, AMIQUINSIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Amiquinsin hydrochloride bears US NLM identifiers UMLS ID C0953995 and NCI Concept Code C75237. SMILES: COC1CC2C(CCNC2CC1OC)N.O.CL.

UNSPSC 51433506 Amiquinsin hydrochloride, a Commodity code, encompasses advanced life support medications and pharmaceutical products supplied to state and local emergency services, health agencies, and multi-state cooperative purchasing programs. State and local governments procure under this code to stock emergency medical supplies for fire rescue operations, support pharmacy benefit programs, and establish framework agreements for generic pharmaceuticals and over-the-counter products distributed across multiple jurisdictions. The work spans sealed competitive bids for specific medication line items with firm pricing and delivery commitments, exploratory requests for information on direct-to-manufacturer pharmaceutical contracting models, and multi-award RFPs establishing tiered supplier relationships with authorized wholesalers. Issuing bodies include municipal fire rescue departments, state health and human services agencies, and regional cooperative purchasing alliances serving multiple states; the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) and the Texas Health and Human Services Commission appear as active procurers in the recent record.

Recent activity spans Florida, Texas, and Minnesota. The City of Tampa's Purchasing Department issued sealed-bid solicitation 26P00188 for Advanced Life Support Medications (Hillsborough County Fire Rescue) with a response deadline of April 8, 2026 and an estimated contract value of $40,000, requiring delivery within ten calendar days and nine-month minimum expiration dates on all supplied medications; the award goes to the lowest responsive, responsible bidder, with a 5 percent bid discount available for Small Local Business Enterprise participation. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 (same-day deadline) to gather vendor capabilities for implementing direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP, issued RFP S1070000015802 with a March 26, 2026 response deadline to establish multi-award contracts for generic multi-source pharmaceuticals and OTC products supplied through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson, with contract effectiveness July 1, 2026 and evaluation weighted 75 percent on price competitiveness.